MEDI-9314
- Generic Name
- MEDI-9314
Safety and Tolerability of MEDI9314 as Single Ascending Dose in Healthy Subjects
- First Posted Date
- 2016-02-01
- Last Posted Date
- 2019-06-04
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 44
- Registration Number
- NCT02669667
- Locations
- 🇬🇧
Research Site, Harrow, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath